ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - PH
|
|
Winsolo
|
102 |
36K |
25 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
102
|
36K
|
25
|
|
ASX - By Stock
|
IMU |
Re:
Management only take up 54.46% of shares
|
|
Winsolo
|
17 |
5.5K |
8 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
17
|
5.5K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Management only take up 54.46% of shares
|
|
Winsolo
|
17 |
5.5K |
17 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
17
|
5.5K
|
17
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - LC
|
|
Winsolo
|
7 |
2.9K |
3 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
7
|
2.9K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: IMUGENE ANNOUNCES A$80 MILLION INSTITUTIONAL PLACEMENT
|
|
Winsolo
|
327 |
154K |
13 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
327
|
154K
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Trading Halt
|
|
Winsolo
|
255 |
159K |
24 |
12/09/22 |
12/09/22 |
ASX - By Stock
|
255
|
159K
|
24
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FIRST COHORT 3 PATIENT DOSED IN CLINICAL TRIAL OF CHECKVACC
|
|
Winsolo
|
77 |
48K |
28 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
77
|
48K
|
28
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Final HER-Vaxx Phase 2 Trial Overall Survival Results
|
|
Winsolo
|
439 |
229K |
2 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
439
|
229K
|
2
|
|
ASX - By Stock
|
PSC |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
Winsolo
|
3 |
1.7K |
1 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
3
|
1.7K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Clarification Announcement
|
|
Winsolo
|
407 |
166K |
7 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
407
|
166K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Termination of Supply Agreement
|
|
Winsolo
|
448 |
255K |
14 |
02/05/22 |
02/05/22 |
ASX - By Stock
|
448
|
255K
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Winsolo
|
15K |
7.2M |
8 |
03/03/22 |
03/03/22 |
ASX - By Stock
|
15K
|
7.2M
|
8
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Encouraging data from 2nd dose cohort in CLTX CAR T trial
|
|
Winsolo
|
27 |
8.0K |
8 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
27
|
8.0K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Winsolo
|
15K |
7.2M |
33 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
15K
|
7.2M
|
33
|
|
ASX - By Stock
|
IMU |
Re:
Ann: HER-Vaxx Immunotherapy Patent Granted in Europe
|
|
Winsolo
|
79 |
36K |
8 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
79
|
36K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA IND APPROVAL FOR THE PHASE 2 CLINICAL TRIAL OF HER-VAXX
|
|
Winsolo
|
167 |
90K |
29 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
167
|
90K
|
29
|
|
ASX - By Stock
|
IMU |
Re:
Ann: South Korea HERVaxx Patent Grant
|
|
Winsolo
|
78 |
38K |
5 |
06/01/22 |
06/01/22 |
ASX - By Stock
|
78
|
38K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene completes Phase 1a trial of immunotherapy PD1-Vaxx
|
|
Winsolo
|
180 |
106K |
7 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
180
|
106K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene HER-Vaxx Immunotherapy Patent Allowed in China
|
|
Winsolo
|
161 |
89K |
22 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
161
|
89K
|
22
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - PH
|
|
Winsolo
|
59 |
30K |
7 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
59
|
30K
|
7
|
|
ASX - By Stock
|
TYR |
Re:
Ann: COVID-19 Trading Update 90 - Week Ended 3 December 2021
|
|
Winsolo
|
15 |
4.5K |
0 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
15
|
4.5K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Transformative Portfolio Expansion Presentation
|
|
Winsolo
|
5 |
2.5K |
4 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
5
|
2.5K
|
4
|
|
ASX - By Stock
|
C1X |
Re:
Ann: ASX Market Release - Admission and Quotation
|
|
Winsolo
|
3 |
1.9K |
2 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
3
|
1.9K
|
2
|
|
ASX - By Stock
|
TLG |
Re:
Ann: Tripartite LOI Update
|
|
Winsolo
|
367 |
118K |
0 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
367
|
118K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Results of Meeting Percentages
|
|
Winsolo
|
67 |
35K |
23 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
67
|
35K
|
23
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Results of Meeting
|
|
Winsolo
|
206 |
100K |
21 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
206
|
100K
|
21
|
|
ASX - By Stock
|
IMU |
Re:
Clinicaltrials.gov has CF33-hNIS-antiPDL1 for Triple Negative Breast Cancer trial listed
|
|
Winsolo
|
130 |
85K |
140 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
130
|
85K
|
140
|
|
ASX - By Stock
|
MNS |
Re:
Ann: Response to media article
|
|
Winsolo
|
170 |
76K |
22 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
170
|
76K
|
22
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer
|
|
Winsolo
|
252 |
138K |
17 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
252
|
138K
|
17
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Winsolo
|
15K |
7.2M |
3 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
15K
|
7.2M
|
3
|
|
ASX - By Stock
|
PER |
Re:
ANPNB - what is this?
|
|
Winsolo
|
7 |
2.5K |
3 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
7
|
2.5K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Becoming a substantial holder
|
|
Winsolo
|
44 |
12K |
11 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
44
|
12K
|
11
|
|
ASX - By Stock
|
PER |
Re:
Ann: Prospectus
|
|
Winsolo
|
79 |
21K |
6 |
08/11/21 |
08/11/21 |
ASX - By Stock
|
79
|
21K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and Eureka Therapeutics onCARlytics Collaboration
|
|
Winsolo
|
60 |
40K |
27 |
02/11/21 |
02/11/21 |
ASX - By Stock
|
60
|
40K
|
27
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive PDCO opinion and A$20m Placement
|
|
Winsolo
|
166 |
50K |
2 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
166
|
50K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and Eureka Therapeutics onCARlytics Collaboration
|
|
Winsolo
|
60 |
40K |
2 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
60
|
40K
|
2
|
|
ASX - By Stock
|
NVX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Winsolo
|
68 |
32K |
0 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
68
|
32K
|
0
|
|
ASX - By Stock
|
MNS |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Winsolo
|
7 |
4.8K |
11 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
7
|
4.8K
|
11
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Winsolo
|
143 |
51K |
3 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
143
|
51K
|
3
|
|
ASX - By Stock
|
MNS |
Re:
Ann: Aquifer Permit Approved for NY Lithium-ion Battery Plant
|
|
Winsolo
|
39 |
15K |
15 |
22/10/21 |
22/10/21 |
ASX - By Stock
|
39
|
15K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Winsolo
|
15K |
7.2M |
8 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
15K
|
7.2M
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Clinicaltrials.gov has CF33-hNIS-antiPDL1 for Triple Negative Breast Cancer trial listed
|
|
Winsolo
|
130 |
85K |
5 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
130
|
85K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Clinicaltrials.gov has CF33-hNIS-antiPDL1 for Triple Negative Breast Cancer trial listed
|
|
Winsolo
|
130 |
85K |
0 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
130
|
85K
|
0
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX data demonstrates key OmniCAR features in next gen CAR-T
|
|
Winsolo
|
76 |
37K |
6 |
13/10/21 |
13/10/21 |
ASX - By Stock
|
76
|
37K
|
6
|
|
ASX - By Stock
|
NVX |
Re:
Ann: Change in substantial holding
|
|
Winsolo
|
12 |
9.4K |
16 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
12
|
9.4K
|
16
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Investor Presentation
|
|
Winsolo
|
185 |
88K |
7 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
185
|
88K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Annual Report to shareholders
|
|
Winsolo
|
46 |
30K |
23 |
04/10/21 |
04/10/21 |
ASX - By Stock
|
46
|
30K
|
23
|
|
ASX - By Stock
|
PER |
Re:
Ann: New data supports ATL1102s broader clinical potential
|
|
Winsolo
|
66 |
24K |
15 |
24/09/21 |
24/09/21 |
ASX - By Stock
|
66
|
24K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
S&P to admit Imugene into ASX300 on Friday.
|
|
Winsolo
|
69 |
43K |
8 |
17/09/21 |
17/09/21 |
ASX - By Stock
|
69
|
43K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
That's a lot of volume going through today
|
|
Winsolo
|
35 |
18K |
7 |
17/09/21 |
17/09/21 |
ASX - By Stock
|
35
|
18K
|
7
|
|